Explore 3 Stock Ideas & Industry Insights Download Free Report

Renishaw PLC

Technology GB RSW

5455.0GBX
25.00(0.46%)

Last update at 2026-06-03T15:38:00Z

Day Range

5355.005490.00
LowHigh

52 Week Range

2056.134422.03
LowHigh

Fundamentals

  • Previous Close 5430.00
  • Market Cap2730.46M
  • Volume73350
  • P/E Ratio36.80
  • Dividend Yield2.08%
  • EBITDA122.01M
  • Revenue TTM737.26M
  • Revenue Per Share TTM10.13
  • Gross Profit TTM 332.55M
  • Diluted EPS TTM1.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 118.00M 122.59M 145.06M 145.59M 139.44M
Minority interest 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Net income 83.76M 96.89M 116.10M 120.35M 111.46M
Selling general administrative 77.10M 75.08M 74.89M 69.74M 69.26M
Selling and marketing expenses 144.03M 139.90M 137.74M 122.45M 110.09M
Gross profit 330.83M 421.74M 350.67M 357.55M 295.71M
Reconciled depreciation 35.75M 32.83M 30.27M 36.03M 39.00M
Ebit 110.21M 123.24M 145.47M 158.36M 118.79M
Ebitda 133.90M 156.07M 175.73M 194.39M 157.80M
Depreciation and amortization 23.69M 32.83M 30.27M 36.03M 39.00M
Non operating income net other - - - - -
Operating income 107.89M 108.67M 134.49M 143.25M 138.34M
Other operating expenses 605.16M 582.63M 552.68M 517.41M 449.20M
Interest expense 6.04M 0.64M 0.73M 0.95M 1.33M
Tax provision 34.24M 25.70M 28.96M 25.23M 27.98M
Interest income 13.16M 12.02M 7.94M 0.83M 0.62M
Net interest income 7.12M 11.37M 7.21M -0.11500M -0.70600M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 34.24M 25.70M 28.96M 25.23M 27.98M
Total revenue 713.04M 691.30M 688.57M 671.08M 565.56M
Total operating expenses 222.95M 218.28M 214.78M 203.89M 179.34M
Cost of revenue 382.21M 269.56M 337.91M 313.53M 269.85M
Total other income expense net 10.12M 13.93M 7.59M -7.77100M 22.86M
Discontinued operations - - - - -
Net income from continuing ops 83.76M 96.89M 116.10M 120.35M 111.46M
Net income applicable to common shares - - 116.10M 120.35M 111.46M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 1135.22M 1051.38M 1043.54M 992.77M 856.88M
Intangible assets 2.53M 36.11M 35.23M 32.77M 33.29M
Earning assets - - - - -
Other current assets 60.02M 26.45M 174.87M 174.87M 169.19M
Total liab 209.36M 148.56M 146.88M 177.60M 153.55M
Total stockholder equity 926.44M 903.40M 897.24M 815.75M 703.91M
Deferred long term liab - - 32.44M 28.75M 25.48M
Other current liab 106.76M 50.62M 80.77M 101.75M 79.27M
Common stock 14.56M 14.56M 14.56M 14.56M 14.56M
Capital stock 14.56M 14.56M 14.56M 14.56M 14.56M
Retained earnings 901.17M 876.99M 871.78M 798.54M 674.60M
Other liab - - 38.94M 33.27M 34.45M
Good will 10.85M 11.23M 11.23M 11.45M 10.51M
Other assets - - 139.50M 112.42M 65.50M
Cash 87.42M 122.29M 81.39M 153.16M 95.01M
Cash and equivalents - - - - -
Total current liabilities 137.46M 100.95M 102.32M 132.70M 103.98M
Current deferred revenue - 10.88M -7.70300M -4.63300M -4.89600M
Net debt -71.77500M -103.74900M -68.06100M -136.90300M -74.99700M
Short term debt 4.76M 4.71M 7.70M 4.63M 4.90M
Short long term debt 0.76M 0.75M 4.69M 0.92M 0.99M
Short long term debt total 15.64M 18.54M 13.33M 16.26M 20.01M
Other stockholder equity -2.09800M -2.92100M -886.33500M -813.09900M -689.16100M
Property plant equipment - - 294.49M 253.80M 258.67M
Total current assets 628.30M 586.62M 573.11M 590.51M 497.76M
Long term investments - - - - -
Net tangible assets - - 883.21M 800.28M 685.60M
Short term investments 186.23M 95.54M 125.00M 100.00M 120.00M
Net receivables 135.17M 180.41M 123.43M 127.55M 148.97M
Long term debt 2.12M 2.77M 0.00000M 5.16M 6.46M
Inventory 159.47M 161.93M 185.76M 162.48M 113.56M
Accounts payable 25.94M 21.33M 21.55M 30.95M 24.71M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 12.81M 14.77M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -0.40400M
Accumulated amortization - - - - -
Non currrent assets other 115.34M 130.00M 87.12M 60.77M 18.73M
Deferred long term asset charges - - - - -
Non current assets total 506.93M 464.76M 470.43M 402.25M 359.12M
Capital lease obligations 12.76M 15.02M 8.63M 10.18M 12.56M
Long term debt total - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -128.63900M -31.50400M -94.67700M -6.64900M -110.74900M
Change to liabilities - - -15.01300M 12.29M 27.22M
Total cashflows from investing activities -128.63900M -31.50400M -94.67700M -6.64900M -133.80800M
Net borrowings -0.79400M -0.79900M -5.12000M -5.05500M -7.65600M
Total cash from financing activities -55.81300M -52.70300M -61.39600M -55.89000M -18.23100M
Change to operating activities - - -1.48600M -2.01500M 0.67M
Net income 83.76M 96.89M 116.10M 120.35M 111.46M
Change in cash -34.87300M 40.91M -71.77400M 58.15M -15.37800M
Begin period cash flow 122.29M 81.39M 153.16M 95.01M 110.39M
End period cash flow 87.42M 122.29M 81.39M 153.16M 95.01M
Total cash from operating activities 147.90M 124.08M 84.30M 121.47M 135.29M
Issuance of capital stock - - - - -
Depreciation 32.94M 32.83M 30.27M 36.03M 39.00M
Other cashflows from investing activities -82.36600M 29.27M 7.23M 11.94M 0.62M
Dividends paid 55.42M 55.41M 53.41M 49.49M 10.19M
Change to inventory 2.46M 23.83M -23.27500M -48.91900M -8.06600M
Change to account receivables -11.02500M -23.71900M -12.37900M -11.30100M -25.70300M
Sale purchase of stock -0.15400M 0.00000M -2.21300M -0.75000M -
Other cashflows from financing activities 4.84M 3.51M -7.98900M -6.39600M -4.56500M
Change to netincome - - -9.91900M 15.04M -9.28900M
Capital expenditures 46.27M 74.77M 84.85M 39.66M 23.72M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -7.43300M 3.91M -52.15300M -49.94700M -5.88500M
Stock based compensation 0.79M 0.88M 0.68M 0.18M 0.17M
Other non cash items 37.84M -10.42700M -7.21000M -1.29500M 0.66M
Free cash flow 101.62M 49.30M -0.55400M 81.81M 111.57M

Peer Comparison

Sector: Technology Industry: Scientific & Technical Instruments

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
RSW
Renishaw PLC
25.00 0.46% 5455.00 36.80 20.41 3.70 2.87 3.25 15.89
OXIG
Oxford Instruments PLC
70.00 2.17% 3302.00 95.78 21.41 2.97 3.94 2.84 27.01
JDG
Judges Scientific Plc
-115.0 2.64% 4235.00 53.21 21.01 2.01 3.38 2.26 9.70
SRT
SRT Marine Systems plc
-5.5 6.15% 84.00 87.00 8.15 2.13 7.62 2.24 32.10
QTX
Quartix Holdings Plc
- -% 267.50 17.31 13.85 3.05 3.28 2.89 8.64

Reports Covered

Stock Research & News

Profile

Renishaw plc, an engineering and scientific technology company, designs, manufactures, distributes, sells, and services technological products and services, and analytical instruments and medical devices worldwide. It operates through two segments: Manufacturing technologies; and Analytical instruments and medical devices. The company offers precision measurement and process control products, such as co-ordinate measuring machine probes, software, retrofits, equator gauging systems, fixtures, machine calibration and optimization, machine tool probes, precision styli for metrology, and smart manufacturing data platform; and position and motion control products comprising interferometric laser, magnetic, and optical encoders. It also provides healthcare products, such as neuromate stereotactic robots, neuroinfuse drug delivery systems, neuroinspire surgical planning software, dixi medical's, and Raman spectrometers; industrial robots; and additive 3D printing manufacturing systems. It serves the aerospace, automotive, consumer electronics, medical and healthcare, heavy, machine builder, energy, and precision manufacturing industries, as well as scientific, research, and analysis industries. The company was incorporated in 1973 and is based in Wotton-under-Edge, the United Kingdom.

Renishaw PLC

New Mills, Wotton-under-Edge, United Kingdom, GL12 8JR

Key Executives

Name Title Year Born
Sir David R. McMurtry CBE, CEng, FIMechE, FREng, FRS, RDI Co-Founder & Exec. Chairman 1940
Mr. William Lee M.A., M.B.A. Chief Exec. & Director NA
Mr. David John Deer Co-Founder & Non-Exec. Deputy Chairman 1938
Mr. Allen C. G. Roberts F.C.A., FCA Group Fin. Director & Director 1949
Mr. Dave Wallace Director of Group Operations 1971
Ms. Jacqueline Conway Gen. Counsel & Company Sec. NA
Mr. Chris Pockett Head of Communications NA
Mr. Leo Somerville Pres of Americas 1958
Mr. Rhydian Pountney Managing Director of UK & ROW 1961
Mr. Rainer Lotz Pres of EMEA 1965

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.